HTG Announces First Collaborator in Early Access Program for its Prototype Whole Transcriptome Panel

TUCSON, Ariz. , Dec. 18, 2020 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that it has signed up the first collaborator in its recently announced Early Access Program for its